THE SHKRELI PLAYBOOK - Big Pharma Blocks Generic Manufacturers

From Just Killing Time · 28:48

Show by Elizabeth Stanton

💊 The Shkreli Playbook: The Wall Around a 62-Year-Old PillIn September 2015, a decades-old medicine for a parasite infection jumped from $13.50 a pill to $750. Everyone remembers the smirk in the hearing room. Almost nobody remembers what the government actually sued over. 🔍In this deep dive, Elizabeth Stanton unpacks the Daraprim (DAIR-uh-prim) story: the 1950s lab behind pyrimethamine (pir-ih-METH-uh-meen), the two moves that allegedly kept generic makers out, the House and Senate hearings, the securities fraud conviction that had nothing to do with the pill, and the antitrust case that finally ended in a lifetime ban and a $64.6 million order. We also cover the CREATES (kree-AYTS) Act and the October 2026 FTC contempt filing.⏱️ IN THIS EPISODE🎬 The Fifth Amendment, four times🧱 Buy it, lock it🏛️ A general counsel who objected and was fired⚖️ Judge Cote's ruling📜 A law that arrived years late ❓ QUICK ANSWERSWho is Martin Shkreli (SKREH-lee)? Former head of Turing Pharmaceuticals, later Vyera (vy-AIR-uh), convicted of securities fraud in 2017.What is Daraprim? A medicine for toxoplasmosis (TOK-so-plaz-MOH-sis).What did the FTC sue over? Blocking generic competition, not the price tag itself.What was the penalty? A lifetime pharmaceutical industry ban and $64.6 million. 🧠 WHY IT MATTERSThis is not just a story about one personality. It is a story about a method: buy a drug with no competition, control the supply and the samples, and let the price do the rest. Hearings made headlines, but the price stayed at $750. The CREATES Act, aimed at sample-blocking, was signed on December 20, 2019, and the first U.S. generic followed in February 2020. 🕰️❓ MORE QUICK ANSWERSWas he prosecuted for the price hike? No. His 2018 seven-year sentence came from securities fraud tied to Retrophin (RET-roh-fin).Who ruled in the antitrust case? Judge Denise Cote (KOHT), in January 2022.Did the ruling hold? The Second Circuit upheld it in January 2024.What happened in October 2026? The FTC asked a federal court to hold Shkreli in contempt for allegedly violating the ban.Who testified at the Senate hearing? Former Turing general counsel Howard Dorfman.🎬 Story beats: the hearing room, the 1950s lab, the two moves, the Senate, the wrong crime, the law that showed up late. Ask your own pharmacist what a drug costs and why, then tell us what you hear.🗣️ Opinions are labeled as opinions. Facts come with sources. Sources differ on a few details, and we say so out loud.📚 SOURCESCBS News/AP, Feb. 4, 2016; U.S. Senate Special Committee on Aging, Hearing 114-849, Mar. 17, 2016; Fortune, Mar. 17, 2016; Morning Consult, Mar. 17, 2016; Salt Lake Tribune/AP, Mar. 17, 2016; U.S. Attorney's Office E.D.N.Y., Mar. 9, 2018; KCUR/NPR, Mar. 10, 2018; CT Public/NPR, Jan. 14, 2022; AP, Jan. 14, 2022; Business Insurance/Reuters, Jan. 14, 2022; N.C. Department of Justice, Jan. 2024; FTC statement, Jan. 23, 2024; Covington & Burling, Jan. 13, 2020; FDA CREATES Act page; Bloomberg Government, Oct. 13, 2026; Law&Crime, Jan. 2024. 🎧 Just Killing Time is a podcast about truth, crime, conspiracies and a little hidden history sprinkled in. Subscribe, rate and share it with a friend.📩 Tell your story: [email protected]📱 Follow the Podcast on TikTok @just.killing.time.pod🔎 Martin Shkreli, Daraprim, Turing Pharmaceuticals, Vyera, drug price gouging, FTC antitrust, CREATES Act, true crime, hidden history, conspiracy podcast #Shkreli #Daraprim #DrugPrices #TrueCrimePodcast #HiddenHistory #JustKillingTime

More episodes of Just Killing Time

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.